Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPERION
2010-021062-29Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferasirox and deferoxamine in hemochromatosis (HH), sponsored by Novartis. Primary endpoint: Change in cardiac iron content at Month 12. Started Oct 2010; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
hemochromatosis (HH)
Beyond the preview
Go deeper on 2010-021062-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021062-29.